07 mar, 2019 Grifols enters a strategic alliance with Shanghai RAAS to boost growth of its plasma-derived products and diagnostic solutions in China

28 feb, 2019 Grifols reports EUR 4,487 million in revenues, with 9.2% operating growth and EUR 597 million in net profit

21 feb, 2019 Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year

07 feb, 2019 Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System

23 jan, 2019 Grifols Announces Collaboration and License Agreement with Rigel Pharmaceuticals

08 jan, 2019 Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions

19 dec, 2018 Grifols partners with the Republic of Liberia to explore an innovative approach to combat Ebola virus disease

15 nov, 2018 Grifols introduces AlfaCare in Spain, the first support program for patients with Alpha-1 Antitrypsin Deficiency (AATD)

05 nov, 2018 Bioscience Division revenues drive operational growth to 9.6% in the third quarter and boost net profits to Euros 468 million

27 oct, 2018 Grifols AMBAR results demonstrate a significant reduction in the progression of moderate Alzheimer's Disease

22 oct, 2018 Grifols invests in ultrahigh sensitive disease diagnostic and prognostic technology

12 oct, 2018 FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing

08 oct, 2018 Grifols Delivers Promise of Advancing Plasma-derived Medicines through Innovative Vision and Donor Support

07 sep, 2018 Grifols and the European Investment Bank sign an Euros 85 million long-term loan to support its R+D+i initiatives

04 sep, 2018 FDA Approves Grifols New GamaSTAN® (immune globulin [human]) to Treat Patients Exposed to Hepatitis A and Measles

16 aug, 2018 Grifols Announces Winner of the 2018 SPIN Award for Immunoglobulin Research in Neurology at the 2018 Peripheral Nerve Society Annual Meeting

14 aug, 2018 Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System

03 aug, 2018 Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins

01 aug, 2018 Grifols expands its plasma collection network by acquiring 24 Biotest centers in the United States

27 jul, 2018 Grifols increases net profits by 15% to EUR 319 million, with sustained operational revenue growth of 7%


1 2 3 ... 16 17 Next >>